PhRMA Statement Regarding Research Partnerships and Clinical Trials

Washington, D.C. (April 12, 2012) — Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John J. Castellani issued the following statement today:

“Today, two important reports were released that together paint a vivid picture of the role of collaboration in the research ecosystem – one by highlighting partnerships with academic medical centers (AMCs) and one by highlighting the contributions patients make to medical research by participating in clinical trials.

PhRMA: Compulsory Licensing in India

Washington, D.C. (March 13, 2012) — PhRMA President and CEO John Castellani issued the following statement today, on India issuing a compulsory license:

“The research based pharmaceutical industry believes that all people around the world should have access to quality healthcare and lifesaving medicines. In partnership with other stakeholders, the industry is committed to playing a full part in addressing the healthcare challenges of the developing world by taking an innovative, responsible, and, above all, sustainable approach.

PhRMA Statement on Human Brain Mapping Initiative

WASHINGTON, D.C. (February 18, 2013) – Pharmaceutical Research and Manufacturers of America (PhRMA) Senior Vice President Matthew Bennett issued the following statement today regarding a new initiative by the Administration that could help further medical research for neurological diseases:

New Drug Approvals in 2011

Research in Texas

Research in Tennessee

Research in Your Backyard: Developing Cures, Creating Jobs - Pharmaceutical Clinical Trials in Minnesota

Research in Illinois

Biopharmaceutical Research Companies are Developing Nearly 200 Medicines for the Most Common Chronic Health Problem in the United States

How You Can Help Fight a $1.1 Trillion Disease

Washington, D.C. (November 21, 2011) — In honor of Alzheimer's disease month, the Pharmaceutical Research and Manufacturers of America (PhRMA) produced a compelling video series highlighting the impact this devastating disease has on patients, caregivers and the U.S. health care system.


Subscribe to RSS - Innovation